Skip to main content
. 2020 Feb 28;16(1):41–48. doi: 10.17925/EE.2020.16.1.41

Table 3: Injection practices in ‘pain-present’ and ‘pain-free’ subgroups of the study subjects.

Parameter Total patients (N=847) Pain present (n=473) Pain free (n=374) p*
Insulin device
Syringe 68.1 73.2 61.8 <0.001
Pen 31.9 26.8 38.2
Main site of injection
Abdomen 63.6 60.3 67.9 0.022
Other than abdomen 36.4 39.7 32.1
Needle reuse
≤2 times 1.7 1.1 2.5 0.001
3–5 times 22.2 24.6 19.2
6–10 times 35.4 30.4 41.9
>10times 40.7 43.9 36.4
Needle length
4 mm 8.3 11.8 3.7 <0.001
5 mm 14.4 10.4 19.5
6 mm 31.8 26.4 38.5
8 mm 40.5 44.8 35.0
12 mm 5.1 6.6 3.2
Injects into a skinfold
Yes 89.7 90.1 89.3 0.401
No 10.3 9.9 10.7
Angle of needle entry
90 degrees 64.6 59.8 70.6 0.001
Other than 90 degrees 35.4 40.2 29.4
Bleeding
Yes 35.5 44.8 23.8 <0.001
No 64.5 55.2 76.2

Data are presented as % unless otherwise stated.

*p-value by Chi-square test.